Skip to main content
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
28.57
+0.24 (0.85%)
At close: Mar 9, 2026, 4:00 PM EDT
28.62
+0.05 (0.18%)
After-hours: Mar 9, 2026, 7:01 PM EDT

HRMY Revenue

In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth. Harmony Biosciences Holdings had revenue of $243.78M in the quarter ending December 31, 2025, with 21.12% growth.

Revenue (ttm)
$868.45M
Revenue Growth
+21.51%
P/S Ratio
1.90
Revenue / Employee
$2,964,003
Employees
293
Market Cap
1.65B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Innoviva 411.33M
Immunocore Holdings 400.02M
AnaptysBio 234.60M
Nurix Therapeutics 83.98M
Intellia Therapeutics 67.67M
Nuvation Bio 62.90M
Agios Pharmaceuticals 54.03M
Oculis Holding AG 1.51M
Revenue Rankings

HRMY News

More News